PROMETIC LIFE SCIENCES — prometic.com
ProMetic is a biopharmaceutical corporation with globally recognized expertise in bioseparation and uses its own affinity technology for the development of best in class plasma-derived therapeutics. ProMetic is also active in developing its own novel small molecule therapeutics products. Headquartered in Laval, Canada, ProMetic has a global presence through its various sites in the UK and USA, providing both manufacturing and R&D capability. These strategic locations facilitate ProMetic’s growth globally and supports all business activity in American, European and Asian markets. ProMetic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).
ProMetic has developed core competencies in strategic fields, including:
- Purification of biologics
- Drug development
- Proteomics
- Elimination of pathogens
LINK: Prometic press releases
The business is now focused on developing its range of therapeutics from both its plasma-derived and small-molecule platform.
______________________________________________________________________________________
WELCOME! —This is a moderated board. No spam, ad hominem attacks or flaming. One warning.
______________________________________________________________________________________ |
